Cwm, LLC Axsome Therapeutics, Inc. Transaction History

Cwm, LLC

$20.6 Billion
Q1 2024

A detailed history of Cwm, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Cwm, LLC holds 29,595 shares of AXSM stock, worth $2.37 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

29,595

Previous 38,371 22.87%

Holding current value

$2.37 Million

Previous $3.05 Million 22.66%

% of portfolio

0.01%

Previous 0.02%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 05, 2024	SELL	$69.39 - $97.64 $608,966 - $856,888	-8,776 Reduced 22.87%	29,595 $2.36 Million
Q4 2023 Feb 01, 2024	SELL	$57.42 - $83.61 $101,001 - $147,069	-1,759 Reduced 4.38%	38,371 $3.05 Million
Q3 2023 Oct 11, 2023	BUY	$69.25 - $82.21 $838,202 - $995,069	12,104 Added 43.19%	40,130 $2.81 Million
Q2 2023 Aug 03, 2023	BUY	$58.41 - $90.35 $1.64 Million - $2.53 Million	27,996 Added 93320.0%	28,026 $2.01 Million
Q4 2022 Feb 01, 2023	BUY	$39.94 - $79.72 $399 - $797	10 Added 50.0%	30 $2,000

Q2 2022 Jul 28, 2022	SELL	$21.74 - $46.75 $195 - $420	-9 Reduced 31.03%	20 $1,000
Q1 2022 Apr 21, 2022	SELL	$23.7 - $41.39 $1,469 - $2,566	-62 Reduced 68.13%	29 $1,000
Q4 2021 Jan 31, 2022	SELL	$30.7 - $43.36 $2.8 Million - $3.96 Million	-91,326 Reduced 99.9%	91 $3,000
Q1 2021 Sep 15, 2021	BUY	$55.91 - $81.44 $275,859 - $401,824	4,934 Added 5.71%	91,417 $6.17 Million
Q1 2021 Apr 27, 2021	SELL	$55.91 - $81.44 $275,859 - $401,824	-4,934 Reduced 5.4%	86,483 $4.9 Million
Q4 2020 Sep 15, 2021	BUY	$66.31 - $86.52 $606,935 - $791,917	9,153 Added 11.13%	91,417 $6.17 Million
Q4 2020 Jan 27, 2021	SELL	$66.31 - $86.52 $606,935 - $791,917	-9,153 Reduced 10.01%	82,264 $6.7 Million
Q3 2020 Sep 15, 2021	BUY	$68.34 - $85.84 $2.4 Million - $3.02 Million	35,172 Added 62.53%	91,417 $6.17 Million
Q3 2020 Oct 19, 2020	SELL	$68.34 - $85.84 $2.4 Million - $3.02 Million	-35,172 Reduced 38.47%	56,245 $4.01 Million
Q2 2020 Sep 15, 2021	BUY	$49.87 - $98.69 $1.48 Million - $2.94 Million	29,767 Added 48.28%	91,417 $6.17 Million
Q2 2020 Jul 22, 2020	SELL	$49.87 - $98.69 $1.48 Million - $2.94 Million	-29,767 Reduced 32.56%	61,650 $5.07 Million
Q1 2020 Sep 15, 2021	BUY	$41.2 - $101.31 $3.77 Million - $9.26 Million	91,417 New	91,417 $6.17 Million
Q1 2020 Apr 28, 2020	SELL	$41.2 - $101.31 $3.77 Million - $9.26 Million	-91,417 Closed	0 $0
Q4 2019 Sep 14, 2021	BUY	$16.71 - $106.24 $1.53 Million - $9.71 Million	91,417 New	91,417 $6.17 Million
Q4 2019 Jan 27, 2020	SELL	$16.71 - $106.24 $1.53 Million - $9.71 Million	-91,417 Closed	0 $0
Q3 2019 Sep 14, 2021	BUY	$20.24 - $29.16 $1.85 Million - $2.67 Million	91,417 New	91,417 $6.17 Million
Q3 2019 Oct 22, 2019	SELL	$20.24 - $29.16 $1.85 Million - $2.67 Million	-91,417 Closed	0 $0
Q2 2019 Sep 14, 2021	BUY	$13.46 - $25.75 $1.23 Million - $2.35 Million	91,417 New	91,417 $6.17 Million
Q2 2019 Jul 31, 2019	SELL	$13.46 - $25.75 $1.23 Million - $2.35 Million	-91,417 Closed	0 $0
Q1 2019 Sep 02, 2021	BUY	$2.63 - $16.34 $240,426 - $1.49 Million	91,417 New	91,417 $0

Others Institutions Holding AXSM

# of Institutions

290

Shares Held

37.1M

Call Options Held

401K

Put Options Held

464K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.44B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account